Canopy Growth vs Tilray Brands
CGC and TLRY side by side, both in drugs. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How CGC and TLRY compare
Tilray Brands grew revenue faster over the last twelve months (15.9% versus 10.7% for Canopy Growth).
Tilray Brands keeps more of each dollar of sales as profit, with a net margin of −17.1% compared with −87.0% at Canopy Growth.
Tilray Brands scores higher on the StockData Score (11 against 3 for Canopy Growth), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | CGC | TLRY |
|---|---|---|
| Size and price | ||
| Market cap | – | $359M |
| Share price | $0.561 | $2.43 |
| Change, 1 year | −52.8% | −80.2% |
| Change, 5 years | −99.5% | −97.8% |
| Beta (5Y) | 1.89 | 1.53 |
| Employees | 1,128 | 3,595 |
| StockData Score | ||
| Total score | 3 | 11 (better) |
| Valuation score | 0 | 3 (better) |
| Growth score | 1 | 3 (better) |
| Performance score | 1 | 3 (better) |
| Health score | 1 | 2 (better) |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/S | – | 0.4× |
| P/B | – | 0.2× |
| Fair value | – | $17.55 |
| Margin of safety | – | 86.2% |
| Growth | ||
| Revenue growth (TTM) | 10.7% | 15.9% (better) |
| Revenue growth, 5Y average | −12.2% | 40.5% (better) |
| Profitability | ||
| Gross margin | 24.4% | 29.1% (better) |
| Operating margin | −54.2% | −9.3% (better) |
| Net margin | −87.0% | −17.1% (better) |
| FCF margin | −25.8% | – |
| Return on equity | – | −10.4% |
| Return on invested capital | – | −5.0% |
| Financial health | ||
| Debt / equity | – | 0.08 |
| Interest coverage | −3.7× | – |
| Current ratio | 2.82 (better) | 1.88 |
| Altman Z-score | – | −2.23 |
| Piotroski F-score | 5 (better) | 3 |
| Dividends and buybacks | ||
| Buyback yield | – | −43.9% |
| Shareholder yield | – | −43.9% |
| Ownership | ||
| Held by institutions | 6.9% | 9.5% |
| Held by insiders | 1.0% | 2.0% |
| Insider net buying, 12 months | −$393K | −$164K (better) |
| Short interest, % of float | – | 13.5% |
Go deeper
- CGC stock overview
- CGC income statement
- CGC valuation and score
- TLRY stock overview
- TLRY income statement
- TLRY valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.